Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Carisma Therapeutics Inc (CARM)

Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,576
  • Shares Outstanding, K 41,543
  • Annual Sales, $ 14,920 K
  • Annual Income, $ -86,880 K
  • 60-Month Beta 1.00
  • Price/Sales 3.93
  • Price/Cash Flow N/A
  • Price/Book 5.22
Trade CARM with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.36
  • Number of Estimates 2
  • High Estimate -0.29
  • Low Estimate -0.43
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +26.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3450 +4.83%
on 05/15/24
1.9100 -26.18%
on 04/23/24
-0.2200 (-13.50%)
since 04/19/24
3-Month
1.3450 +4.83%
on 05/15/24
2.7700 -49.10%
on 03/01/24
-1.0000 (-41.49%)
since 02/20/24
52-Week
1.3450 +4.83%
on 05/15/24
9.7662 -85.56%
on 07/17/23
-3.2000 (-69.41%)
since 05/19/23

Most Recent Stories

More News
Carisma Therapeutics to Present at Upcoming Investor Conferences

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.4100 (unch)
Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.4100 (unch)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.4100 (unch)
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.4100 (unch)
Carisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.4100 (unch)
Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma Therapeutics" or the "Company"), a clinical stage biopharmaceutical company focused on...

CARM : 1.4100 (unch)
Carisma Therapeutics to Present at Upcoming Investor Conferences in June 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.4100 (unch)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.4100 (unch)
Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.4100 (unch)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma"), a clinical stage biopharmaceutical company focused on discovering and developing...

CARM : 1.4100 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in...

See More

Key Turning Points

3rd Resistance Point 1.5165
2nd Resistance Point 1.4832
1st Resistance Point 1.4466
Last Price 1.4100
1st Support Level 1.3767
2nd Support Level 1.3434
3rd Support Level 1.3068

See More

52-Week High 9.7662
Fibonacci 61.8% 6.5493
Fibonacci 50% 5.5556
Fibonacci 38.2% 4.5619
Last Price 1.4100
52-Week Low 1.3450

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar